Log in to save to my catalogue

Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7410081

Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

About this item

Full title

Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2020-08, Vol.130 (8), p.4104-4117

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Diabetes, obesity, and Alzheimer's disease (AD) are associated with vascular complications and impaired nitric oxide (NO) production. Furthermore, increased β-site amyloid precursor protein-cleaving (APP-cleaving) enzyme 1 (BACE1), APP, and β-amyloid (Aβ) are linked with vascular disease development and increased BACE1 and Aβ accompany hyperglycemi...

Alternative Titles

Full title

Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7410081

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7410081

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI122237

How to access this item